Adam Kovalčík, 19, receives $100,000 Top Award for his development of a medicine that can stop viruses from copying genes and controlling infections at the world’s largest pre-college STEM competition in Columbus, Ohio

TARRYTOWN, N.Y. and WASHINGTON, May 16, 2025 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. and Society for Science (the Society) announced that Adam Kovalčík, 19, of Dulovce, Slovakia, won the $100,000 George D. Yancopoulos Innovator Award at the 75th Regeneron International Science and Engineering Fair (Regeneron ISEF), the world’s largest pre-college science and engineering competition. The award is named in honor of pioneering drug developer and Regeneron co-Founder, Board co-Chair, President and Chief Scientific Officer. Other top prizes went to projects in sustainable plastics engineering, air quality detection and advancement in prosthetics.

The top winners were recognized during two award ceremonies: the Special Awards on May 15 and the Grand Awards Ceremony on May 16. In total, more than $9 million in awards and scholarships were distributed, honoring finalists for their creativity, innovative thinking and scientific rigor. The competition brought together nearly 1,700 young scientists representing 48 U.S. states and more than 60 countries, regions and territories.

Adam Kovalčík, 19, of Dulovce, Slovakia, won first place and received the $100,000 George D. Yancopoulos Innovator Award for his new way of making the investigational antiviral drug galidesivir. Early clinical trials have shown this drug to be safe in humans. Animal tests show it may be effective against a broad spectrum of viruses. But it is expensive to produce. By starting with cheap materials from corn husk waste, he designed a shorter, more efficient way of making galidesivir. He cut the process from 15 to 10 steps and made almost twice as much drug in less time. He then used these reactions to create a new antiviral drug that may work even better. His new way to make these medicines can greatly decrease their cost, from $75/gram to about $12.50/gram. By making these medicines easier to produce, they are also easier to study, and if approved, more accessible, giving us more options to treat viral infections.

Benjamin Davis, 16, of Wrentham, Massachusetts, received the $75,000 Regeneron Young Scientist Award for creating a desktop plastic recycling system. The user-friendly system can recycle 3D printer waste and other plastics. It turns them into filaments for 3D printing. Up to 67% of the filament used in a typical 3D printing project may end up as waste. Using electrical, mechanical and chemical engineering methods, Benjamin combined pultrusion (push-through) and extrusion (pull-through) processes. Together, this made the process about 45% more efficient. His device is faster than other home recyclers and creates a higher quality product. Its easy operation means nontechnical users can recycle and 3D print more efficiently. His design is an effective recycling machine that costs 90% less than commercial options.

Siyaa Poddar, 16, of Chandler, Arizona, received the $75,000 Regeneron Young Scientist Award for her device, which rapidly detects toxic dusts. In the U.S. Southwest, toxic silica and uranium dusts from abandoned mines are a public health challenge. They contaminate the soil, air and groundwater, and can trigger autoimmune diseases like Sjögren’s syndrome. Rates of Sjögren’s syndrome are disproportionately high on Indigenous reservations in the Southwest, where many abandoned mines remain. Currently, there’s no easy, fast or affordable way to measure how much of these toxins are in the air. Siyaa designed two low-cost detectors using chemicals that easily react with uranium or silica by changing color. She trapped these chemicals in a framework made of metal atoms and organic molecules to stabilize them. Her system is an affordable, easy-to-use way to monitor air quality.

Samuel Skotnikov, 17, of Highland Village, Texas, and Chanyoung Kim and Eeshaan Prashanth, both 16, of Flower Mound, Texas, received the $50,000 Gordon E. Moore Award for Positive Outcomes for Future Generations for creating a brain-controlled bionic prosthetic leg. Current robotic limbs are expensive and can make movements feel unnatural. The team started by measuring the walking motion of their classmate, Aiden, with his usual prosthetic leg. They saw that the prosthetic’s stiffness forced the remaining part of his amputated leg to work much harder than his other leg. They designed their prosthetic leg, Neuroflex, to read the wearer’s brain signals through an EEG headband. The signals tell Neuroflex how the wearer wants to move, and Neuroflex uses its motors to support that movement. They also designed an ankle with more realistic joints. When the team tested their prototype on Aiden, it guessed the right movement 98% of the time. Their adaptable model could also relieve some of the cost burden of prosthetic limbs.

“Congratulations to the winners of this year’s Regeneron International Science and Engineering Fair,” said Maya Ajmera, President and CEO of Society for Science and Executive Publisher of Science News. “I am deeply inspired by the creative, passionate and dedicated finalists from around the world who have come together—across borders, cultures and scientific disciplines —in the shared pursuit of science. Adam’s research into antiviral medicines has the potential to change the impact and scale of how people can benefit from such important life-saving treatments. His research gives me great hope for the future of global health and scientific innovation.”

Now in its landmark 75th year, Regeneron ISEF remains the premier global stage for the next generation of scientists and engineers. This milestone year celebrates decades of scientific discovery, boundary-pushing innovation and international collaboration, uniting students from around the world in a powerful exchange of ideas. Through Regeneron ISEF and other STEM programming, Regeneron and the Society are fostering the next generation of STEM leaders who are pioneering solutions to improve our world. Since 2020, Regeneron has provided STEM experiences to over 3.2 million students, surpassing its goal of 2.5 million by 2025.

“Congratulations to this year’s extraordinary Regeneron ISEF finalists and winners,” said George D. Yancopoulos, M.D., Ph.D., co-Founder, Board co-Chair, President and Chief Scientific Officer of Regeneron. “My own high school science project lit a fire in me that changed the course of my life. Today, I see these students carrying that same spark forward by asking bold questions, pushing boundaries and proving that innovative science can take on humanity’s biggest challenges.”

Other top honors from the competition include:

XinYan Chen, 17, of San Gabriel, California, received the $10,000 Craig R. Barrett Award for Innovation for her mobile indoor formaldehyde detector. Formaldehyde is a chemical found in many household goods that can cause disease, including cancer. Other detectors work by either trapping chemicals until they are full, or by breaking them down with expensive materials. XinYan designed a low-cost material that breaks down formaldehyde into carbon dioxide and water. She used the material to build a device that measures and destroys the poison at the same time. Her device lowered the amount of formaldehyde in a closed box by almost 90% in 18 hours. XinYan’s device makes it cheaper and easier to both measure and improve indoor air quality.

Aleksandra Petkova, 18, of Sofia, Bulgaria, received the $10,000 H. Robert Horvitz Prize for Fundamental Research for her research on the relationship between a boat’s speed and the shape of its wake. When a boat travels faster than the waves it makes in the water, it makes a narrower wake. This type of wake creates more drag on the boat, which slows it down. Aleksandra looked at aerial photos of wakes and tested wake angles using a remote-controlled boat and a yacht. She figured out how to use a ship’s size to predict the speed it can travel before it starts leaving a narrow wake. Aleksandra’s ship wake model could help ship operators minimize drag by traveling at the ideal speeds for their ships.

Cory Seelenfreund, 17, of New Rochelle, New York, received the $10,000 Peggy Scripps Award for Science Communication for his study of the relevance of memory in the Prisoner’s Dilemma. Prisoner’s Dilemma is a classic game theory problem where two people accused of a crime decide whether to snitch or stay silent. Cory created computer simulations and mathematical models to test how selfishness and memory affect the game. Memory of just one game often improved results, but players with better memory won in more complex scenarios. He found the best outcomes when players had a variety of self-interested and altruistic behaviors. These findings can help design smarter AI bots and other programs that need to “get along” with humans.

Uma Sthanu, 17, of Austin, Texas, received the $10,000 Mary Sue Coleman Award for Life Science Innovation & Impact for her research on regenerating nerve cells. The neurons making up the human brain are powerful but fragile. Disease and injury can damage neurons and scientists have not yet found a way to regrow them. Uma studied the effects of an important hormone-like compound called PGE2 on damaged brain cells. She used advanced techniques to study how PGE2 treatment affects these broken neurons in the lab. She hopes this work will help researchers find better treatments for brain diseases and traumatic brain injuries.

Pragathi Kasani-Akula, 17, of Cumming, Georgia; Aarushi Pandey, 17, of Conroe, Texas; and Vrishank Chandrasekhar, 18, of San Jose, California, received the Dudley R. Herschbach SIYSS Award, which provides finalists an all-expense paid trip to attend the Stockholm International Youth Science Seminar during Nobel Week in Stockholm, Sweden.

Ethan Yan, 15, of Burlingame, California, and Abigail Qi, 16, of Baton Rouge, Louisiana, received the EU Contest for Young Scientists Award. Their projects will represent Regeneron ISEF at the EU Contest for Young Scientists to be held this September in Riga, Latvia.

For more information about the top winners and access to visual assets visit our media kit: https://www.societyforscience.org/regeneron-isef-2025-media-kit/ 

The full list of Special Award ISEF 2025 Finalists can be found at: https://www.societyforscience.org/press-release/regeneron-isef-2025-special-awards-winners

In addition to the Top Award winners, more than 450 finalists received awards and prizes for their innovative research, including “First Award” winners, who each received a $6,000 prize.

The following lists the First Award winners for each of the 22 categories, from which the Top Awards were chosen:

Animal Sciences, sponsored by Society for Science

Matthew Lo, 16, of Berwyn, Pennsylvania

Behavioral and Social Sciences, sponsored by Society for Science

Ameya Kharade, 16, of Nashua, New HampshireJesse Rumball-Smith, 17, of Wellington, New Zealand

Biochemistry, sponsored by Regeneron

Pragathi Kasani-Akula, 17, of Cumming, Georgia 

Biomedical and Health Sciences, sponsored by Regeneron

Edward Kang, 17, of Upper Saddle River, New JerseyUma Sthanu, 17, of Austin, Texas 

Biomedical Engineering, sponsored by Regeneron

Chanyoung Kim, 16, of Flower Mound, TexasEeshaan Prashanth, 17, of Flower Mound, TexasSamuel Skotnikov, 17, of Highland Village, Texas

Cellular and Molecular Biology, sponsored by Regeneron

Lilly Horowitz, 17, of Jericho, New York

Chemistry, sponsored by Arc Institute

Adam Kovalčík, 19, of Dulovce, Slovakia

Computational Biology and Bioinformatics, sponsored by Regeneron

Arnav Sharma, 15, of Troy, MichiganSamarth Dunakhe, 15, of Chandler, ArizonaAryav Das, 16, of Noblesville, IndianaQianheng Xu, 16, of Millburn, New Jersey

Earth and Environmental Sciences, sponsored by Society for Science

Lakshmi Agrawal, 17, of Bellevue, WashingtonMiriam Haddad, 18, of Saginaw, Michigan

Embedded Systems, sponsored by HP

Maya Trutschl, 17, of Shreveport, Louisiana

Energy: Sustainable Materials and Design, sponsored by Siemens Energy

Oliver Wang, 17, of Falls Church, Virginia

Engineering Technology: Statics and Dynamics, sponsored by Howmet Aerospace Foundation

Benjamin Davis, 16, of Wrentham, Massachusetts

Environmental Engineering, sponsored by Jacobs

Bennett Huang, 16, of Great Falls, VirginiaJason Pan, 16, of Great Falls, VirginiaXinYan Chen, 17, of San Gabriel, California

Materials Science, sponsored by Howmet Aerospace Foundation

Siyaa Poddar, 16, of Chandler, Arizona

Mathematics, sponsored by Akamai Foundation

Cory Seelenfreund, 17, of New Rochelle, New York

Microbiology, sponsored by Schattner Foundation

Abigail Qi, 16, of Baton Rouge, Louisiana

Physics and Astronomy, sponsored by Jane Street

Aiden Kwon, 17, of Rolling Hills Estates, California             Aleksandra Petkova, 18, of Sofia, Bulgaria 

Plant Sciences, sponsored by Society for Science

Aarushi Pandey, 17, of Conroe, Texas

Robotics and Intelligent Machines, sponsored by Liquid AI

Chinmayi Goyal, 17, of Yorktown, New YorkTimothy Wilson, 18, of Pennant Hills, Australia

Systems Software, sponsored by Microsoft

Ram Sivaraman, 17, of Acton, Massachusetts

Technology Enhances the Arts, sponsored by Midjourney

Punnawit Ponnirun, 17, of Chiang Mai, ThailandSataporn Thanapanyakul, 17, of Chiang Mai, ThailandSiwakorn Suwannahong, 17, of Chiang Mai, Thailand

Translational Medical Science, sponsored by Regeneron

Audrey Zheng, 16, of Wexford, PennsylvaniaVrishank Chandrasekhar, 18, of San Jose, California

The full list of all award-winning ISEF 2025 finalists is available here.

View all the finalists’ research here.

About the Regeneron International Science and Engineering Fair

The Regeneron International Science and Engineering Fair (Regeneron ISEF), a program of Society for Science celebrating 75 years, is the world’s largest global science competition for high school students. Through a global network of local, regional and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately U.S. $9 million in awards and scholarships.

In 2019, Regeneron became the title sponsor of ISEF to help reward and celebrate the best and brightest young minds globally and encourage them to pursue careers in STEM to positively impact the world. Regeneron ISEF is supported by a community of additional sponsors, Adam R. Scripps Foundation, Akamai Foundation, Aramco, Arc Institute, Gordon and Betty Moore Foundation, Howmet Aerospace Foundation, HP, Insaco, Intel, Jacobs, Jane Street, Liquid AI, Microsoft, Midjourney, Schattner Foundation, Siemens Energy, The Ohio State University, Battelle, Caltech, Cesco, Cisco, COSI, GoFundMe, Jeni’s Splendid Ice Creams, JobsOhio, Johnson Energy Holdings.   Many are entrepreneurs across a wide range of industries. Learn more at https://www.societyforscience.org/isef/.

About Society for Science 

Society for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its STEM Outreach programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).

About Regeneron 

Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic conditions, infectious diseases and rare diseases.

Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious disease, to foster a culture of integrity and excellence and to build sustainable communities. Regeneron is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro-bono and matching gift programs. Our most significant philanthropic commitments are in the area of science education, including the Regeneron Science Talent Search and the Regeneron International Science and Engineering Fair (ISEF). 

For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X. 

Media Contacts
Joseph Brown, Regeneron
386-283-1323, joseph.brown2@regeneron.com    

Gayle Kansagor, Society for Science
703-489-1131, gkansagor@societyforscience.org   

View original content to download multimedia:https://www.prnewswire.com/news-releases/75th-annual-regeneron-international-science-and-engineering-fair-awards-teen-scientists-from-around-the-world-more-than-9-million-in-2025-competition-302458019.html

SOURCE Society for Science

NEW YORK, May 16, 2025 /PRNewswire/ — Fairmint, Inc., a registered SEC Transfer Agent, today published the whitepaper for the Open Captable Protocol (OCP), an open-source, industry-grade standard for recording, managing, and transferring equity ownership on-chain.

The release comes as regulatory momentum builds for on-chain securities innovation, highlighted by SEC Chairman Atkins’ recent address at the Crypto Task Force Roundtable, where he noted that “the migration to on-chain securities has the potential to remodel aspects of the securities market.”

The Open Captable Protocol whitepaper outlines the technical approach to bringing equity securities on-chain through a standardized, legally-compatible framework already adopted by companies ranging from early-stage startups to established private enterprises.

“Private equity has long been held back by fragmented files and manual workflows,” said Joris Delanoue, Co-founder and CEO of Fairmint. “The Open Captable Protocol builds on the foundation set by the Open Cap Table Coalition to bring standardization and speed, reducing transfer times from weeks to seconds while preserving full regulatory compliance. This turns static securities into dynamic financial instruments that can be leveraged in ways previously too complex or expensive to execute.”

Fairmint’s design emphasizes compliance, legal clarity, and operational simplicity. Unlike token-centric frameworks, OCP implements cap tables as programmable smart contracts with embedded rules and legal enforceability, minimizing issuer risk while enabling programmatic compliance.

“We’ve built this technology to work within today’s regulatory environment while creating new possibilities for tomorrow,” explained Thibauld Favre, Co-founder and Chief Technical Officer.

Fairmint encourages regulated intermediaries—transfer agents, broker-dealers, custodians, and infrastructure providers—to adopt OCP as a shared standard for compliant, on-chain equity management.

“The Open Captable Protocol provides a secure, compliant foundation that regulated agents can immediately implement to enhance their service offerings,” added Delanoue. “By adopting a common standard, we can collectively build a more efficient private securities ecosystem while maintaining the regulatory guardrails that investors and issuers expect.”

The whitepaper details real-world implementations, with use cases such as Fairmint, Inc., Transfer Agent XYZ, and Plural Brokerage LLC, a registered broker-dealer and FINRA/SIPC member, all of which use OCP as a settlement layer.

The complete OCP whitepaper is available at fairmint.com/whitepaper/open-cap-table-protocol

About Fairmint, Inc.
Fairmint, Inc. provides infrastructure for on-chain equity management, enabling efficient issuance, administration, and compliant transfer of private securities. Founded in 2019 by Joris Delanoue and Thibauld Favre, Fairmint is headquartered in New York, NY, and serves private companies, financial institutions, and infrastructure providers looking to modernize their equity workflows. Fairmint operates as a registered U.S. Transfer Agent.

For more information, please visit www.fairmint.com

Contact:
Joris Delanoue
***@fairmint.com

PRLog ID: www.prlog.org/13077076

View original content:https://www.prnewswire.com/news-releases/fairmint-releases-whitepaper-for-open-captable-protocol-ocp-to-advance-on-chain-equity-securities-302457888.html

SOURCE Fairmint, Inc.

Equity Insider News Commentary

Issued on behalf of Avant Technologies Inc.

VANCOUVER, BC, May 16, 2025 /PRNewswire/ — Equity Insider News Commentary – AI is no longer just assisting healthcare — it’s beginning to rewire it from the ground up. From streamlining diagnostics and automating clinical documentation to predicting disease and optimizing hospital operations, generative AI is now touching every layer of the care continuum. As policymakers in places like Connecticut debate how to regulate this growing influence, and initiatives like OpenAI’s HealthBench push the frontier of model evaluation, a new class of enterprise-scale innovators is already moving ahead. Among them are several public companies straddling health tech, cloud AI, and data infrastructure — including Avant Technologies, Inc. (OTCQB: AVAI), Palantir Technologies Inc. (NASDAQ: PLTR), GE HealthCare Technologies Inc. (NASDAQ: GEHC), Salesforce, Inc. (NYSE: CRM), and Alphabet Inc. (NASDAQ: GOOG, GOOGL).

Industry analysts at MarketsandMarkets project that the AI in healthcare market will expand at a compound annual growth rate of 38.6%, reaching over $110 billion by 2030. Looking further ahead, Accenture estimates that AI could unlock an additional $461 billion in value by 2035—augmenting a global healthcare sector already expected to exceed $2.26 trillion.

Avant Technologies, Inc. (OTCQB: AVAI) is quietly but deliberately advancing its position in AI-powered healthcare through a proposed acquisition of its joint venture partner, Ainnova Tech. The two companies, already aligned under the Ai-nova Acquisition Corp. (AAC) banner, are now moving to unify operations—an intentional step that comes just ahead of their scheduled FDA pre-submission meeting this July. If completed, the merger would remove internal friction, streamline clinical trial planning, and strengthen their regulatory posture ahead of potential U.S. market entry.

“We believe bringing the two companies together will offer tremendous value for shareholders,” said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of Ai-nova Acquisition Corp. “It will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally.”

At the core of this effort is Vision AI, a non-invasive clinical screening platform that combines retinal imaging, vital sign capture, and machine-learning algorithms to detect early signals of chronic illness—including diabetic retinopathy, cardiovascular disease, kidney and liver conditions, and type 2 diabetes. Operating under AAC, the joint venture holds global rights to the platform, which has shown more than 90% sensitivity in early detection, according to NIH-cited research.

“This milestone reflects our two-tiered strategy, rapid deployment in low-regulation markets where Vision AI operates as a screening tool, and simultaneous progress toward FDA clearance for the U.S. market,” said Vargas. “Entering the U.S. will unlock significant commercial potential, and early engagement with regulators ensures we do so with speed, credibility, and a validated product.”

Unlike many healthcare AI startups still stuck at concept stage, Avant’s technology is already deployed in Latin America—including Chile, Mexico, and Brazil—where it’s being tested in real-world clinical workflows. These field programs are not only helping build a safety and efficacy track record, they’re also providing critical user feedback that shapes the platform’s refinement and usability.

To support broader clinical reach, AAC recently integrated four new diagnostic algorithms into Vision AI. Trained on over 2.3 million clinical cases, these additions enhance the system’s utility across a wider range of chronic conditions. With proven traction abroad and a pending regulatory milestone in the U.S., Avant is moving from potential to presence—and may soon find itself on the radar of a much larger healthcare conversation.

CONTINUED… Read this and more news for Avant Technologies at:

https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/ 

Palantir Technologies Inc. (NASDAQ: PLTR) has entered a long-term partnership with The Joint Commission, the leading healthcare accreditation body in the U.S., to apply its AI and data analytics platform to improve patient safety and operational efficiency.

“The Joint Commission is committed to building the accreditation and certification process of the future, today,” says Alex Karp, co-founder and CEO of Palantir Technologies. “This work will improve global health outcomes by utilizing AI to drive performance improvements around the world.”

The collaboration aims to modernize how hospitals manage quality standards, streamline certification processes, and enhance clinical performance. Palantir’s platform is already delivering results across major healthcare systems, including Tampa General and Cleveland Clinic.

GE HealthCare Technologies Inc. (NASDAQ: GEHC) recently unveiled CleaRecon DL, an FDA-cleared, AI-based solution aimed at elevating image quality in cone-beam CT (CBCT) procedures. Powered by deep learning, the tool addresses long-standing image distortion challenges caused by blood flow and contrast variability, especially in interventional settings like liver and neuro procedures. Clinical validation shows a 94% increase in interpretation confidence and a 98% improvement in image clarity compared to traditional CBCT.

“The introduction of CleaRecon DL represents a leap forward in the interventional suite and for the advancement of CBCT,” said Arnaud Marie, General Manager, Interventional Solutions at GE HealthCare. “By improving image quality and reducing artifacts, this technology can empower clinicians to perform procedures with greater precision and confidence. This solution builds on our portfolio of tools aimed at improving the user experience and workflow efficiency, enabling clinicians to deliver more accurate and effective interventions for enhanced patient outcomes.”

Salesforce, Inc. (NYSE: CRM) is expanding its healthcare footprint with the launch of a global Life Sciences Partner Network and broader deployment of its Agentforce digital labor platform. Designed to unify clinical, commercial, and manufacturing data, the initiative enables pharmaceutical and medtech organizations to transition from legacy systems to AI-enabled, compliant workflows.

“We are in an unprecedented market moment where, with digital labor grounded in rich data, international life sciences organizations have the opportunity to completely reimagine the way they interact with patients and HCPs,” said Frank Defesche, Senior Vice President and General Manager, Salesforce Life Sciences. “Backed by over two decades of industry expertise, Salesforce is uniquely equipped to pioneer this next era with our deeply unified Platform that brings together apps, data, life sciences-specific workflows, and AI – all wrapped in trust and compliance.”

With integrations from partners like athenahealth, Viz.ai, and H1, the platform supports real-time insights, patient engagement, and automated compliance across the healthcare lifecycle. This marks a major step in Salesforce’s push to become the digital backbone of modern life sciences operations.

Alphabet Inc. (NASDAQ: GOOG, GOOGL), through Google Cloud and Google Public Sector, has partnered with Drive Health and the State of Illinois to launch Healthy Baby, a multi-year AI-powered maternal health pilot targeting underserved communities. The program equips expectant mothers with Google Pixel phones and Fitbit devices, delivering personalized care through Nurse Avery, an AI health assistant.

“The Healthy Baby pilot represents a critical step in maternal healthcare, showing how AI can help deliver personalized, proactive health support directly to underserved mothers,” said Chris Hein, Field Chief Technology Officer, Google Public Sector. “Using the AI agent, Nurse Avery, and delivering it through Google Pixel phones and Fitbit devices, the program provides real-time support – managing appointments, monitoring vitals, and offering health guidance directly, aiming to make essential resources more readily available.”

Backed by Google Cloud’s secure infrastructure, the initiative aims to reduce maternal mortality, improve birth outcomes, and close care gaps across rural populations.

Source: https://equity-insider.com/2025/03/21/unlocking-the-trillion-dollar-ai-market-what-investors- need-to-know/ 

CONTACT:

Equity Insider
info@equity-insider.com
(604) 265-2873

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Logo – https://mma.prnewswire.com/media/2644233/5323825/Equity_Insider_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/new-healthcare-ai-models-could-reshape-everything-from-burnout-to-diagnostics-302458037.html